These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12443769)

  • 1. Synthesis of new Targretin analogues that induce apoptosis in leukemia HL-60 cells.
    Winum JY; Baghdiguian S; Commes T; Leydet A; Montero JL
    Bioorg Med Chem Lett; 2002 Dec; 12(24):3529-32. PubMed ID: 12443769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oral bexarotene (targretin) on the minimal erythema dose for broadspectrum UVB light.
    Smit JV; De Jong EM; Van De Kerkhof PC
    Skin Pharmacol Appl Skin Physiol; 2003; 16(4):237-41. PubMed ID: 12784063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bexarotene ligand pharmaceuticals.
    Hurst RE
    Curr Opin Investig Drugs; 2000 Dec; 1(4):514-23. PubMed ID: 11249708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid hormone regulation of apoptosis induced by retinoic acid in promyeloleukemic HL-60 cells: studies with retinoic acid receptor-specific and retinoid x receptor-specific ligands.
    Hara M; Suzuki S; Mori J; Yamashita K; Kumagai M; Sakuma T; Kakizawa T; Takeda T; Miyamoto T; Ichikawa K; Hashizume K
    Thyroid; 2000 Dec; 10(12):1023-34. PubMed ID: 11201846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells.
    Boehm MF; Zhang L; Zhi L; McClurg MR; Berger E; Wagoner M; Mais DE; Suto CM; Davies JA; Heyman RA
    J Med Chem; 1995 Aug; 38(16):3146-55. PubMed ID: 7636877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling, synthesis and biological evaluation of potential retinoid X receptor-selective agonists: novel halogenated analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene).
    Furmick JK; Kaneko I; Walsh AN; Yang J; Bhogal JS; Gray GM; Baso JC; Browder DO; Prentice JL; Montano LA; Huynh CC; Marcus LM; Tsosie DG; Kwon JS; Quezada A; Reyes NM; Lemming B; Saini P; van der Vaart A; Groy TL; Marshall PA; Jurutka PW; Wagner CE
    ChemMedChem; 2012 Sep; 7(9):1551-66. PubMed ID: 22927238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling, synthesis and biological evaluation of potential retinoid X receptor (RXR) selective agonists: novel analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic acid (bexarotene).
    Wagner CE; Jurutka PW; Marshall PA; Groy TL; van der Vaart A; Ziller JW; Furmick JK; Graeber ME; Matro E; Miguel BV; Tran IT; Kwon J; Tedeschi JN; Moosavi S; Danishyar A; Philp JS; Khamees RO; Jackson JN; Grupe DK; Badshah SL; Hart JW
    J Med Chem; 2009 Oct; 52(19):5950-66. PubMed ID: 19791803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of adipocyte-specific gene expression is correlated with mammary tumor regression by the retinoid X receptor-ligand LGD1069 (targretin).
    Agarwal VR; Bischoff ED; Hermann T; Lamph WW
    Cancer Res; 2000 Nov; 60(21):6033-8. PubMed ID: 11085524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines.
    Song JI; Lango MN; Hwang JD; Drenning SD; Zeng Q; Lamph WW; Grandis JR
    Cancer Res; 2001 Aug; 61(15):5919-25. PubMed ID: 11479234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of retinoid receptors RAR alpha and RXR alpha induces differentiation and apoptosis, respectively, in HL-60 cells.
    Mehta K; McQueen T; Neamati N; Collins S; Andreeff M
    Cell Growth Differ; 1996 Feb; 7(2):179-86. PubMed ID: 8822201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of retinoid treatment of rats on hepatic microsomal metabolism and cytochromes P450. Correlation between retinoic acid receptor/retinoid x receptor selectivity and effects on metabolic enzymes.
    Howell SR; Shirley MA; Ulm EH
    Drug Metab Dispos; 1998 Mar; 26(3):234-9. PubMed ID: 9492386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rexinoids isolated from Sophora tonkinensis with a gene expression profile distinct from the synthetic rexinoid bexarotene.
    Inoue M; Tanabe H; Nakashima K; Ishida Y; Kotani H
    J Nat Prod; 2014 Jul; 77(7):1670-7. PubMed ID: 24959987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selective ligand.
    Gottardis MM; Bischoff ED; Shirley MA; Wagoner MA; Lamph WW; Heyman RA
    Cancer Res; 1996 Dec; 56(24):5566-70. PubMed ID: 8971154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel silicon-containing analogues of the retinoid agonist bexarotene: syntheses and biological effects on human pluripotent stem cells.
    Bauer JB; Lippert WP; Dörrich S; Tebbe D; Burschka C; Christie VB; Tams DM; Henderson AP; Murray BA; Marder TB; Przyborski SA; Tacke R
    ChemMedChem; 2011 Aug; 6(8):1509-17. PubMed ID: 21726055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [LGD1069: an antagonist to the X retinoid receptor].
    Lansiaux A; Formstecher P; Bailly C
    Bull Cancer; 2000 Mar; 87(3):235-8. PubMed ID: 10779810
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action.
    Zhang C; Hazarika P; Ni X; Weidner DA; Duvic M
    Clin Cancer Res; 2002 May; 8(5):1234-40. PubMed ID: 12006543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformationally defined retinoic acid analogues. 5. Large-scale synthesis and mammary cancer chemopreventive activity for (2E,4E,6Z,8E)-8-(3',4'-dihydro-1'(2'H)-naphthalen-1'-ylidene)-3,7-dimethyl-2,4,6-octatrienoic acid (9cUAB30).
    Atigadda VR; Vines KK; Grubbs CJ; Hill DL; Beenken SL; Bland KI; Brouillette WJ; Muccio DD
    J Med Chem; 2003 Aug; 46(17):3766-9. PubMed ID: 12904083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bexarotene: a promising anticancer agent.
    Qu L; Tang X
    Cancer Chemother Pharmacol; 2010 Jan; 65(2):201-5. PubMed ID: 19777233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ-specific expression profiles of rat mammary gland, liver, and lung tissues treated with targretin, 9-cis retinoic acid, and 4-hydroxyphenylretinamide.
    Wang Y; Yao R; Maciag A; Grubbs CJ; Lubet RA; You M
    Mol Cancer Ther; 2006 Apr; 5(4):1060-72. PubMed ID: 16648578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enantioselective syntheses of potent retinoid X receptor ligands: differential biological activities of individual antipodes.
    Vuligonda V; Thacher SM; Chandraratna RA
    J Med Chem; 2001 Jul; 44(14):2298-303. PubMed ID: 11428923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.